The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism

Pipeline of anti‐ Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities

(2021) Anna Egorova et al.   MEDICINAL RESEARCH REVIEWS

Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus

(2020) Matt D. Johansen et al.   NATURE REVIEWS MICROBIOLOGY

Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3

(2020) Giulia Degiacomi et al.   Applied Sciences-Basel

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

(2020) Charles L Daley et al.   CLINICAL INFECTIOUS DISEASES

MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections

(2020) Jigar P. Sethiya et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Indole-2-carboxamides are Active Against an Acute Mycobacterium abscessus Infected Mouse Model

(2019) Amit N. Pandya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis

(2019) Nakwon Kwak et al.   EUROPEAN RESPIRATORY JOURNAL

Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target

(2019) Bing Zhang et al.   CELL

The FICI paradigm: Correcting flaws in antimicrobial in vitro synergy screens at their inception

(2019) Marta Gómara et al.   BIOCHEMICAL PHARMACOLOGY

Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients

(2019) Degiacomi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus

(2019) Clément Raynaud et al.   ACS Infectious Diseases

NTM drug discovery: status, gaps and the way forward

(2018) Mu-Lu Wu et al.   DRUG DISCOVERY TODAY

Drugs in Development for Malaria

(2018) Elizabeth A. Ashley et al.   DRUGS

MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections

(2018) Wei Li et al.   Frontiers in Microbiology

Discovery of benzothiazole amides as potent antimycobacterial agents

(2018) James Graham et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in Mycobacterium abscessus Drug Resistance

(2018) Sakshi Luthra et al.   Frontiers in Microbiology

Nontuberculous Mycobacterial Infections in Cystic Fibrosis

(2018) Stacey L. Martiniano et al.   Thoracic Surgery Clinics

Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections

(2017) Alan P. Kozikowski et al.   JOURNAL OF MEDICINAL CHEMISTRY

MmpL3 is the flippase for mycolic acids in mycobacteria

(2017) Zhujun Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression

(2017) Giulia Degiacomi et al.   Scientific Reports

Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3

(2016) Wei Li et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis

(2016) Elizabeth L. Salsgiver et al.   CHEST

A new piperidinol derivative targeting mycolic acid transport inMycobacterium abscessus

(2016) Christian Dupont et al.   MOLECULAR MICROBIOLOGY

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary

(2015) R Andres Floto et al.   THORAX

MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212

(2011) Valentina La Rosa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY